Laísa Vilar Cordeiro, Helivaldo Diógenes da Silva Souza, Giulian César da Silva Sá, Aleson Pereira Sousa, Thiago Ramalho De Figueiredo, Maria das Neves Silva Neta, J. Barbosa Filho, E. de Oliveira Lima
{"title":"Coumarin (2H-1-Benzopyran-2-one) act against planktonic and biofilm forms of Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa","authors":"Laísa Vilar Cordeiro, Helivaldo Diógenes da Silva Souza, Giulian César da Silva Sá, Aleson Pereira Sousa, Thiago Ramalho De Figueiredo, Maria das Neves Silva Neta, J. Barbosa Filho, E. de Oliveira Lima","doi":"10.15446/rcciquifa.v50n3.100226","DOIUrl":null,"url":null,"abstract":"Introduction: biofilm-related infections caused by Staphylococcus aureus, Klebsi-ella pneumoniae and Pseudomonas aeruginosa are difficult to treat and few effective pharmacological options are currently available for this purpose. In this context, coumarin (2H-1-Benzopyran-2-one) has been reported to have antibacterial and antibiofilm activity, but this potential remains poorly understood. Aim: to investi-gate the action of coumarin on planktonic and biofilm forms of S. aureus, K. pneu-moniae and P. aeruginosa. Results: a minimum inhibitory concentration (MIC) of coumarin ranging from 256 to 1024 μg/mL was observed, with a remarkable ability to inhibit the formation of biofilms and to act on mature biofilms in concentrations close to MIC. Conclusion: coumarin has strong activity against planktonic and biofilm forms on the three species of great relevance in the clinical scenario. These results are interesting to enable a pharmacological alternative for the treatment of these infections.","PeriodicalId":21220,"journal":{"name":"Revista Colombiana de Ciencias Químico-Farmacéuticas","volume":"12 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Colombiana de Ciencias Químico-Farmacéuticas","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15446/rcciquifa.v50n3.100226","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: biofilm-related infections caused by Staphylococcus aureus, Klebsi-ella pneumoniae and Pseudomonas aeruginosa are difficult to treat and few effective pharmacological options are currently available for this purpose. In this context, coumarin (2H-1-Benzopyran-2-one) has been reported to have antibacterial and antibiofilm activity, but this potential remains poorly understood. Aim: to investi-gate the action of coumarin on planktonic and biofilm forms of S. aureus, K. pneu-moniae and P. aeruginosa. Results: a minimum inhibitory concentration (MIC) of coumarin ranging from 256 to 1024 μg/mL was observed, with a remarkable ability to inhibit the formation of biofilms and to act on mature biofilms in concentrations close to MIC. Conclusion: coumarin has strong activity against planktonic and biofilm forms on the three species of great relevance in the clinical scenario. These results are interesting to enable a pharmacological alternative for the treatment of these infections.